Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

20. Décembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2927


	Articles 1 - 20 / 58530

	The SÃ£o Paulo International Consensus on Minimally Invasive Pancreatic Surgery for Cancer. HPB (Oxford) Tustumi F, Calthorpe L, Fotoohi N, Ribeiro TC, Stolzemburg LCP, Bettiati Junior AL, Gonçalves CA, de Almeida APCB, Giordano AMG, de Godoy AL, Altenfelder D, Nicioli J, Guimarães AC, Requejo AS, Diniz AL, Oliveira AF, Wei AC, de Moricz A, Montagnini AL, Visser BC, Chan CHF, de Oliveira CVC, Ferrone CR, Asbun D, Jonas E, Ramos EJB, Nickel F, Maia FKO, Apodaca-Torrez FR, Barreto SG, Hewitt DB, de Farias IC, Frigerio I, Jang JY, Anghinoni M, Boff MF, Belotto M, Giménez ME, Nakamura M, Katz MHG, Hogg ME, Kendrick ML, Luyer MDP, Abu Hilal M, Ikoma N, Zyromski NJ, Jarufe N, Guevara OA, Mazza O, Polanco PM, Amaral PCG, Pinheiro RN, Jeyarajah DR, Gaujoux S, Shrikhande SV, Torres SM, Siriwardena AK, Kent TS, Hackert T, Pawlik TM, Andraus W, Boggi U, Asbun HJ, Alseidi A, Coimbra FJF. PMID: 41419350 [PubMed - as supplied by publisher]
	Reply to: "Revisiting Methodologic Paradigms in Local Therapies for Hepatocellular Carcinoma: Insights From the SURF Study" and "Methodologic and Reporting Gaps in the SURF Trial". J Clin Oncol Kawaguchi Y, Kashiwabara K, Matsuyama Y, Kokudo N, Hasegawa K. PMID: 41418085 [PubMed - as supplied by publisher]
	Integrated local and global Ki67 profiling for prognostic stratification and therapeutic guidance in high-grade neuroendocrine neoplasms: a multicenter validation study. Int J Surg Chu J, Gong H, Gao H, Zhu Z, Shi J, Ma Y, Ji Y, Zhang Q, Cao L, Tang F, Liang Y, Chen J, Sheng W, Chen Q, Zhuang X, Huang D. PMID: 41417992 [PubMed - as supplied by publisher]
	Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials. Cancer Saj F, Namayanja FK, Xiao L, Borad MJ, Kelley RK, Goyal L, Azad NS, Bachini M, Lindsey S, Pant S, Valle JW, Fashoyin-Aje LA, Javle M. PMID: 41417596 [PubMed - indexed for MEDLINE]
	Enhanced Recovery After Surgery (ERAS) Protocols in Pancreatic Cancer Resections: Their Impact on Postoperative Morbidity. Cureus Vardhan Reddy GH, Pandya M, Ahirwar HK, Saklani S, Bandyopadhyay S. PMID: 41416298 [PubMed]
	Conversion Resection or Direct Resection for Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicentre Study. Liver Cancer Zhou Y, Wang H, Wu J, Shen J, Ma J, Li Q, Chen W, Lu W, Feng X, Yan M, Wen T, Zhang X. PMID: 41415919 [PubMed - as supplied by publisher]
	Tumor Cell Plasticity in Cancer: Signaling Pathways and Pharmaceutical Interventions. MedComm (2020) Sun S, Sun Y, Lan L, Luan S, Zhou J, Deng J, Yuan Y, Wu Z. PMID: 41415713 [PubMed]
	Complementary strategies in pancreatic cancer precision medicine: therapeutic prediction and immune modulation. Front Oncol Lee W, Woo HM, Cho JH, Kim MS. PMID: 41415544 [PubMed]
	Dose-response relationships of dietary quality with mortality stratified by dietary inflammation and their joint associations among cancer survivors: a population-based cohort study. BMC Public Health Ma Y, Tian Q, Wu X, Sun Y, Tian J, Xu D, Gong M, Li X, Liu Y, Zhu B. PMID: 41413864 [PubMed - as supplied by publisher]
	Magnetic resonance-guided online adaptive stereotactic body radiotherapy for advanced inoperable pancreatic cancer: a prospective study. Radiat Oncol Wang C, Wang Z, Yu L, Guan Q, Dong T, Hou X, Xu H, Zhang Y, Jiang F, Lian X, Hu K, Qiu J, Zhang F. PMID: 41413834 [PubMed - as supplied by publisher]
	Plasma Proteomics Identifies Potential Pancreatic Cancer Risk Indicators in Type 2 Diabetes. Pancreas Chu S, Liu J, Liu X, Sun W, Zhang Q, Song C, Li Q, Gu L, Chang J, Sun L. PMID: 41411515 [PubMed - indexed for MEDLINE]
	Multimodal Care and Outcomes of Pancreatic Cancer Patients Are Influenced by Factors Beyond Biology: A Population-Based Study From Louisiana Tumor Registry. J Surg Oncol Galatas A, Malinosky HR, Chapple AG, McManus S, Byerley A, Littlefield E, Hemelt S, Lyons J, Danos D, Moaven O. PMID: 41410291 [PubMed - as supplied by publisher]
	Assessing the Accuracy of the International Evidence-Based Kyoto Guidelines for Detecting Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. GE Port J Gastroenterol Borges MPF, Rebelo P, Vilas-Boas F, Graça L, Carneiro S, Bouça-Machado T. PMID: 41409549 [PubMed - as supplied by publisher]
	Rechallenge with Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: A Narrative Review. Liver Cancer Li J, Liang YB, Wang QB, Luo WL, Chen XM, Lakang Y, Yang ZS, Zuo JX, Li YK, Li Z, Peng Y, Chen YB, Ke Y. PMID: 41409409 [PubMed - as supplied by publisher]
	Case Report: Pseudoprogression of pancreatic acinar cell carcinoma after PD-1 blockade integrated treatment. Front Immunol Bai X, Yang D, Chen J, Liu Y, Tang H, Kong X, Liu B, Sha H, Du J. PMID: 41409298 [PubMed - indexed for MEDLINE]
	Predictive value of current nodal staging systems and development of machine learning nomogram for resectable pancreatic head cancer: a population-based study and multicenter validation. Front Immunol Zou WB, Zhang XP, Song YY, Xu S, Liu BY, Zhao ZM, Gao YX, Hu MG, Huang G, Liu R. PMID: 41409284 [PubMed - indexed for MEDLINE]
	Adult Pancreatoblastoma: A Challenge in the Differential Diagnosis of Pancreatic Neuroendocrine Neoplasms. Endocr Pathol Guastafierro V, Bouklas DP, Pancetti S, Uccella S. PMID: 41407939 [PubMed - in process]
	Pancreatic metastasis from oncocytic thyroid carcinoma: diagnostic challenges across centres. J Clin Pathol Sethi G, Papadakou E, Moutasim K, Sipaul F, Bateman AC. PMID: 41407542 [PubMed - as supplied by publisher]
	Claudin 18.2 in cancer research and treatment: a pathologist's perspective. J Clin Pathol Murtazaalieva G, Baldwin A, Fassan M, Deshpande V. PMID: 41407541 [PubMed - as supplied by publisher]
	Generate shows nab-paclitaxel plus gemcitabine still an effective regimen for metastatic pancreatic cancer: In this study, mFOLFIRINOX and S-IROX did not demonstrate superior outcomes compared to GnP in patients aged 75 years or younger with metastatic pancreatic cancer. Cancer Lawrence L. PMID: 41405138 [PubMed - in process]

Articles 1 - 20 / 58530

Page 1 de 2927



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité